Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

CVD Risk Factors
Fathers Have Worse Heart Health Than Non-Fathers But Lower Death Rates
05/29/2024

Northwestern University News

Northwestern University News
Since most men in the U.S. are fathers, identifying some of the explanations for the associations among health, disease and fatherhood could have important health implications for men, especially for men of color, the scientists said. 
Since most men in the U.S. are fathers, identifying some of the explanations for the associations among health, disease and fatherhood could have important health implications for men, especially for men of color, the scientists said. 
Since most men in the U.S. are...
05/29/2024
Cath Lab Digest

Advertisement

Nutrition
Study Shows Orange Peel Extract May Improve Heart Health
05/29/2024

University of Florida News

University of Florida News
“These findings suggest that orange peels, often discarded as waste in the citrus industry, can be repurposed into valuable health-promoting ingredients, such as diet supplements or food ingredients,” said researcher Yu Wang.
“These findings suggest that orange peels, often discarded as waste in the citrus industry, can be repurposed into valuable health-promoting ingredients, such as diet supplements or food ingredients,” said researcher Yu Wang.
“These findings suggest that...
05/29/2024
Cath Lab Digest
Heart Failure
International Study Reveals Surprising Twist in How Diabetes Drugs Help the Heart
05/29/2024

Duke-NUS Medical School News

Duke-NUS Medical School News
The trial results, which are the first to be published from this international collaborative project, contradict the prevailing theory that SGLT2 inhibitors reduce congestion through diuresis or increased urine production.
The trial results, which are the first to be published from this international collaborative project, contradict the prevailing theory that SGLT2 inhibitors reduce congestion through diuresis or increased urine production.
The trial results, which are the...
05/29/2024
Cath Lab Digest
Intracardiac Echocardiography (ICE)
Philips Expands Global Access to Its Ground-Breaking 3D Intracardiac Echocardiography to Hong Kong
05/29/2024

Royal Philips News

Royal Philips News
Royal Philips announced that the first hospitals in Hong Kong have started using Philips real-time 3D Intracardiac Echocardiography (ICE) catheter – VeriSight Pro – to aid minimally-invasive image-guided procedures. It is the first time the...
Royal Philips announced that the first hospitals in Hong Kong have started using Philips real-time 3D Intracardiac Echocardiography (ICE) catheter – VeriSight Pro – to aid minimally-invasive image-guided procedures. It is the first time the...
Royal Philips announced that the...
05/29/2024
Cath Lab Digest

Advertisement

Heart Failure
Corveus Medical Named Category Winner at Junkosha Innovator of the Year Award Ceremony
05/29/2024

Junkosha News

Junkosha News
Corveus Medical has developed a catheter to help the millions of congestive heart failure patients around the world, specifically those who are unresponsive to current treatments. This one-time procedure provides a minimally invasive solution...
Corveus Medical has developed a catheter to help the millions of congestive heart failure patients around the world, specifically those who are unresponsive to current treatments. This one-time procedure provides a minimally invasive solution...
Corveus Medical has developed a...
05/29/2024
Cath Lab Digest
Conferences
American College of Cardiology Announces Care of the Athletic Heart
05/28/2024

American College of Cardiology News

American College of Cardiology News ...
In the United States there are over 8 million active athletes. Given the rapid expansion of sports cardiology, cardiovascular care teams must understand contemporary care and practice management strategies for all athletes—from the elite to...
In the United States there are over 8 million active athletes. Given the rapid expansion of sports cardiology, cardiovascular care teams must understand contemporary care and practice management strategies for all athletes—from the elite to...
In the United States there are...
05/28/2024
Cath Lab Digest
RNA Interference Drugs
MUIR Trial: Promising Results for Hyperlipidemia Treatment Reduces Risk of Cardiovascular Events
05/28/2024

Baylor College of Medicine News

Baylor College of Medicine News ...
Plozasiran is an RNA interference drug that targets specific RNA molecules in the body that are responsible for the production of APOC3, a key regulator of triglyceride-rich lipoprotein metabolism. High levels of APOC3, caused by genetics or...
Plozasiran is an RNA interference drug that targets specific RNA molecules in the body that are responsible for the production of APOC3, a key regulator of triglyceride-rich lipoprotein metabolism. High levels of APOC3, caused by genetics or...
Plozasiran is an RNA...
05/28/2024
Cath Lab Digest

Advertisement

Lower-extremity intervention
Cardiovascular Institute of the South (CIS) is First in US to use Aperta NSE (Novel Scoring Elements) PTA Balloon to Treat Lower-Extremity PAD
05/24/2024

Cardiovascular Institute of the South (CIS) News

Cardiovascular Institute of the South...
Distributed by Nipro Medical, the Aperta NSE™ features four nylon scoring elements to provide focused force and an anchoring effect to prepare peripheral arterial lesions for treatment.
Distributed by Nipro Medical, the Aperta NSE™ features four nylon scoring elements to provide focused force and an anchoring effect to prepare peripheral arterial lesions for treatment.
Distributed by Nipro Medical,...
05/24/2024
Cath Lab Digest
semaglutide
FLOW Study: Semaglutide Significantly Reduces Risk of Major Kidney Disease Events, Cardiovascular Outcomes, and Mortality in Patients With Type 2 Diabetes and Chronic Kidney Disease
05/24/2024
The FLOW (Evaluate Renal Function with Semaglutide Once Weekly) study is a double-blind, randomized, placebo-controlled international trial comprising 3,533 patients, with a median follow-up period of 3.4 years.
The FLOW (Evaluate Renal Function with Semaglutide Once Weekly) study is a double-blind, randomized, placebo-controlled international trial comprising 3,533 patients, with a median follow-up period of 3.4 years.
The FLOW (Evaluate...
05/24/2024
Cath Lab Digest
TAVR
Atlantic Health System’s Morristown Medical Center Tops 5,000 TAVR Procedures – First in New Jersey and a Top U.S. Program
05/23/2024
Morristown Medical Center’s Gagnon Cardiovascular Institute’s structural heart program reached a significant milestone of performing over 5,000 transcatheter aortic valve replacement (TAVR) procedures, the first in New Jersey and among the...
Morristown Medical Center’s Gagnon Cardiovascular Institute’s structural heart program reached a significant milestone of performing over 5,000 transcatheter aortic valve replacement (TAVR) procedures, the first in New Jersey and among the...
Morristown Medical Center’s...
05/23/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Subscriber

Cath Lab Digest Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use